Inotiv_Logo_CMYK.png
Bioanalytical Systems, Inc., doing business as Inotiv, Invests in Additional Vivarium Capacity at Facility in West Lafayette, IN
March 09, 2021 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., March 09, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of...
Inotiv_Logo_CMYK.png
I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Toxicology to Drive Growth of Expanding Toxicology Business
August 11, 2020 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of...
basi +seventhwave.jpg
BASi Continues Revenue Growth in Third Quarter of Fiscal 2019
August 14, 2019 08:33 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”) today announced financial results for the three and nine...
Researchers Generate Better Data with BASi’s Redesigned Raturn™
May 21, 2019 08:53 ET | Bioanalytical Systems, Inc.
WEST LAFAYETTE, Ind., May 21, 2019 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) is pleased to announce the launch of the Company’s redesigned Raturn™, a...
Certis Logo.png
Certis Oncology Partners With Reveal Biosciences to Offer Advanced Pre-Clinical Oncology Services
August 13, 2018 15:30 ET | Certis Oncology Solutions, Inc.
SAN DIEGO, Aug. 13, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions and Reveal Biosciences today announced a strategic partnership in which the two companies will collaborate to provide an...
Certis Oncology Announces CLIA Certification for High-Complexity Testing
July 16, 2018 08:00 ET | Certis Oncology Solutions, Inc.
SAN DIEGO, July 16, 2018 (GLOBE NEWSWIRE) -- Certis Oncology Solutions, Inc., a new precision medicine company focused on individualized patient care, today announced that it has received its CLIA...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Announces Third and Final Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo
July 12, 2018 11:59 ET | Alliance for Regenerative Medicine
WASHINGTON, D.C., July 12, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, “Moving...
Earth Science Tech, Inc. Signs Agreement with TransBiotech to start in Vitro & in Vivo in Phase II for Nutraceutical Patents
November 14, 2017 08:00 ET | Earth Science Tech, Inc.
Doral, Nov. 14, 2017 (GLOBE NEWSWIRE) --  Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company that operates in the fields of industrial hemp...
AntiCancer PDOX Reaches Series A Financing Target, Appoints Board
June 01, 2017 16:24 ET | AntiCancer PDOX, Inc.
CHICAGO, June 01, 2017 (GLOBE NEWSWIRE) -- ASCO 2017 -- AntiCancer PDOX, Inc. announced today that it has reached its original Series A financing target and appointed its Board of...
Fate Therapeutics.jpg
Fate Therapeutics Announces Preclinical Data Highlighting Persistent Effector Function of Allogeneic Natural Killer Cell Cancer Immunotherapy
May 16, 2016 08:01 ET | Fate Therapeutics, Inc.
Adaptive NK Cell Therapy Advancing Toward First-in-Human Clinical Trial in Collaboration with University of Minnesota Program to be Presented Today at Innate Killer Summit 2016 SAN DIEGO, May 16,...